CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Miltefosine

米替福新 杂质对照品Miltefosine Impurities

75 个杂质条目75 impurity entries

本页汇总 米替福新 的 75 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 75 impurity reference standards of Miltefosine. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 米替福新(Miltefosine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsDevelopment and validation of an HPLC-MS/MS method for the quantification of the anti-leishmanial drug miltefosine in human skin tissue
    Journal of pharmaceutical and biomedical analysis · 2022 · Roseboom IC et al.  ·  PMID 34634528  ·  DOI
  2. 分析方法Analytical MethodsDevelopment and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography-tandem mass spectrometry
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2008 · Dorlo TP et al.  ·  PMID 18325856  ·  DOI
  3. 分析方法Analytical MethodsQuantification of miltefosine in peripheral blood mononuclear cells by high-performance liquid chromatography-tandem mass spectrometry
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2015 · Kip AE et al.  ·  PMID 26160472  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisMulti-Step Synthesis of Miltefosine: Integration of Flow Chemistry with Continuous Mechanochemistry
    Chemistry (Weinheim an der Bergstrasse, Germany) · 2021 · Patil NB et al.  ·  PMID 34697844  ·  DOI
  • 合成方法SynthesisSynthesis of hexadecylphosphocholine (miltefosine)
    Progress in experimental tumor research · 1992 · Eibl H, Engel J  ·  PMID 1438793  ·  DOI

米替福新 —— 原料药与杂质对照品Miltefosine — drug substance & impurities

共 76 个条目(含原料药本体)76 items incl. the drug substance
Miltefosine structure
原料药 APIAPI
米替福新Miltefosine
Miltefosine
CAS No.58066-85-6
Chemical FormulaC21H46NO4P
Purity>95%询价On request
10mg25mg50mg100mg
1
米替福新杂质1Miltefosine Impurity 1
Miltefosine Impurity 1
CAS No.146801-07-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
2
米替福新杂质2Miltefosine Impurity 2
Miltefosine Impurity 2
CAS No.82721-45-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
3
米替福新杂质3Miltefosine Impurity 3
Miltefosine Impurity 3
CAS No.883723-24-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
4
米替福新杂质4Miltefosine Impurity 4
Miltefosine Impurity 4
CAS No.65956-63-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
5
米替福新杂质5Miltefosine Impurity 5
Miltefosine Impurity 5
CAS No.139256-98-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
6
米替福新杂质6Miltefosine Impurity 6
Miltefosine Impurity 6
CAS No.133261-50-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
7
米替福新杂质7Miltefosine Impurity 7
Miltefosine Impurity 7
CAS No.133293-93-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
8
米替福新杂质8Miltefosine Impurity 8
Miltefosine Impurity 8
CAS No.1434289-80-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
9
米替福新杂质9Miltefosine Impurity 9
Miltefosine Impurity 9
CAS No.85412-60-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
10
米替福新杂质10Miltefosine Impurity 10
Miltefosine Impurity 10
CAS No.756419-96-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
11
米替福新杂质11Miltefosine Impurity 11
Miltefosine Impurity 11
CAS No.508174-86-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
12
米替福新杂质12Miltefosine Impurity 12
Miltefosine Impurity 12
CAS No.250588-40-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
13
米替福新杂质13Miltefosine Impurity 13
Miltefosine Impurity 13
CAS No.110786-47-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
14
米替福新杂质14Miltefosine Impurity 14
Miltefosine Impurity 14
CAS No.1030602-00-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
15
米替福新杂质15Miltefosine Impurity 15
Miltefosine Impurity 15
CAS No.1030601-93-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
16
米替福新杂质16Miltefosine Impurity 16
Miltefosine Impurity 16
CAS No.943023-50-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
17
米替福新杂质17Miltefosine Impurity 17
Miltefosine Impurity 17
CAS No.397871-48-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
18
米替福新杂质18Miltefosine Impurity 18
Miltefosine Impurity 18
CAS No.397871-46-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
19
米替福新杂质19Miltefosine Impurity 19
Miltefosine Impurity 19
CAS No.350037-48-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
20
米替福新杂质20Miltefosine Impurity 20
Miltefosine Impurity 20
CAS No.350037-47-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
21
米替福新杂质21Miltefosine Impurity 21
Miltefosine Impurity 21
CAS No.350037-46-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
22
米替福新杂质22Miltefosine Impurity 22
Miltefosine Impurity 22
CAS No.189999-99-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
23
米替福新杂质23Miltefosine Impurity 23
Miltefosine Impurity 23
CAS No.2770977-34-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
24
米替福新杂质24Miltefosine Impurity 24
Miltefosine Impurity 24
CAS No.2760468-20-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
25
米替福新杂质25Miltefosine Impurity 25
Miltefosine Impurity 25
CAS No.2760468-19-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
26
米替福新杂质26Miltefosine Impurity 26
Miltefosine Impurity 26
CAS No.1650586-84-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
27
米替福新杂质27Miltefosine Impurity 27
Miltefosine Impurity 27
CAS No.1650586-82-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
28
米替福新杂质28Miltefosine Impurity 28
Miltefosine Impurity 28
CAS No.1650586-80-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
29
米替福新杂质29Miltefosine Impurity 29
Miltefosine Impurity 29
CAS No.1650586-78-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
30
米替福新杂质30Miltefosine Impurity 30
Miltefosine Impurity 30
CAS No.1650586-72-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
31
米替福新杂质31Miltefosine Impurity 31
Miltefosine Impurity 31
CAS No.1650586-70-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
32
米替福新杂质32Miltefosine Impurity 32
Miltefosine Impurity 32
CAS No.1650586-68-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
33
米替福新杂质33Miltefosine Impurity 33
Miltefosine Impurity 33
CAS No.1650586-66-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
34
米替福新杂质34Miltefosine Impurity 34
Miltefosine Impurity 34
CAS No.943023-91-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
35
米替福新杂质35Miltefosine Impurity 35
Miltefosine Impurity 35
CAS No.943023-64-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
36
米替福新杂质36Miltefosine Impurity 36
Miltefosine Impurity 36
CAS No.350037-45-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Miltefosine Impurity 37 structure
37
米替福新杂质37Miltefosine Impurity 37
Miltefosine Impurity 37
CAS No.77733-28-9
Chemical FormulaC19H42NO4P
Purity>95%询价On request
10mg25mg50mg100mg
Miltefosine Impurity 38 structure
38
米替福新杂质38Miltefosine Impurity 38
Miltefosine Impurity 38
CAS No.85775-42-4
Chemical FormulaC18H40NO4P
Purity>95%询价On request
10mg25mg50mg100mg
39
米替福新杂质39Miltefosine Impurity 39
Miltefosine Impurity 39
CAS No.2606750-22-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
40
米替福新杂质40Miltefosine Impurity 40
Miltefosine Impurity 40
CAS No.748074-30-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
41
米替福新杂质41Miltefosine Impurity 41
Miltefosine Impurity 41
CAS No.133261-51-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
42
米替福新杂质42Miltefosine Impurity 42
Miltefosine Impurity 42
CAS No.110786-46-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
43
米替福新杂质43Miltefosine Impurity 43
Miltefosine Impurity 43
CAS No.20545-96-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
44
米替福新杂质44Miltefosine Impurity 44
Miltefosine Impurity 44
CAS No.139256-99-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
45
米替福新杂质45Miltefosine Impurity 45
Miltefosine Impurity 45
CAS No.115220-24-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
46
米替福新杂质46Miltefosine Impurity 46
Miltefosine Impurity 46
CAS No.250588-41-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
47
米替福新杂质47Miltefosine Impurity 47
Miltefosine Impurity 47
CAS No.1206209-07-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
48
米替福新杂质48Miltefosine Impurity 48
Miltefosine Impurity 48
CAS No.397871-47-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
49
米替福新杂质49Miltefosine Impurity 49
Miltefosine Impurity 49
CAS No.346687-67-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
50
米替福新杂质50Miltefosine Impurity 50
Miltefosine Impurity 50
CAS No.250588-42-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
51
米替福新杂质51Miltefosine Impurity 51
Miltefosine Impurity 51
CAS No.224445-11-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
52
米替福新杂质52Miltefosine Impurity 52
Miltefosine Impurity 52
CAS No.132630-63-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
53
米替福新杂质53Miltefosine Impurity 53
Miltefosine Impurity 53
CAS No.92989-98-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
54
米替福新杂质54Miltefosine Impurity 54
Miltefosine Impurity 54
CAS No.84601-18-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
55
米替福新杂质55Miltefosine Impurity 55
Miltefosine Impurity 55
CAS No.80714-48-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
56
米替福新杂质56Miltefosine Impurity 56
Miltefosine Impurity 56
CAS No.2992655-03-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
57
米替福新杂质57Miltefosine Impurity 57
Miltefosine Impurity 57
CAS No.2760468-22-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
58
米替福新杂质58Miltefosine Impurity 58
Miltefosine Impurity 58
CAS No.2760468-21-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
59
米替福新杂质59Miltefosine Impurity 59
Miltefosine Impurity 59
CAS No.1434290-55-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
60
米替福新杂质60Miltefosine Impurity 60
Miltefosine Impurity 60
CAS No.943022-07-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
61
米替福新杂质61Miltefosine Impurity 61
Miltefosine Impurity 61
CAS No.679428-44-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
62
米替福新杂质62Miltefosine Impurity 62
Miltefosine Impurity 62
CAS No.350037-52-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
63
米替福新杂质63Miltefosine Impurity 63
Miltefosine Impurity 63
CAS No.350037-51-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
64
米替福新杂质64Miltefosine Impurity 64
Miltefosine Impurity 64
CAS No.350037-50-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
65
米替福新杂质65Miltefosine Impurity 65
Miltefosine Impurity 65
CAS No.350037-49-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
66
米替福新杂质66Miltefosine Impurity 66
Miltefosine Impurity 66
CAS No.143651-06-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
67
米替福新杂质67Miltefosine Impurity 67
Miltefosine Impurity 67
CAS No.110786-48-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
68
米替福新杂质68Miltefosine Impurity 68
Miltefosine Impurity 68
CAS No.93049-97-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
69
米替福新杂质69Miltefosine Impurity 69
Miltefosine Impurity 69
CAS No.91662-74-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
70
米替福新杂质70Miltefosine Impurity 70
Miltefosine Impurity 70
CAS No.741206-04-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
71
米替福新杂质71Miltefosine Impurity 71
Miltefosine Impurity 71
CAS No.687612-35-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
72
米替福新杂质72Miltefosine Impurity 72
Miltefosine Impurity 72
CAS No.2305682-29-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
73
米替福新杂质73Miltefosine Impurity 73
Miltefosine Impurity 73
CAS No.76392-53-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
74
米替福新杂质74Miltefosine Impurity 74
Miltefosine Impurity 74
CAS No.138220-13-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Miltefosine Impurity 77 (Hexadecylphosphoethanolamine) structure
77
米替福新杂质77 (十六烷基磷酸乙醇胺)Miltefosine Impurity 77 (Hexadecylphosphoethanolamine)
Miltefosine Impurity 77 (Hexadecylphosphoethanolamine)
CAS No.57303-02-3
Chemical FormulaC18H40NO4P
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

米替福新 —— 研究文献与合成路线Miltefosine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 米替福新 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Miltefosine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Miltefosine suppression of Pten null T-ALL leukemia via β-catenin degradation through inhibition of pT308-Akt and TGFβ1/Smad3
    Zhang Y, Lee S, Xu W · Biochemical and biophysical research communications · 2020 · 被引 6cited 6

合成与制备工艺专利Synthesis & process patents

  1. New compound alkyl bilineurine phosphodiester (miltefosine)and preparation
    YONGGANG WEI · 公开号 CN101475585CN101475585 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

米替福新 杂质谱研究要点Miltefosine — impurity profiling notes

下面这些是拿到 米替福新 的 76 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 76 impurity entries for Miltefosine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances